Press release

Media Release
DKSH partners with Panion & BF Biotech to expand market in
Taiwan
DKSH Taiwan Ltd.
Date: October 21, 2014
DKSH, the leading Market Expansion Services provider with a focus
on Asia, has signed an agreement with Panion & BF Biotech Inc., a
Taiwanese biotechnical pharmaceutical company, to provide Market
Expansion Services in Taiwan.
Taipei, Taiwan, October 21, 2014 - DKSH Business Unit Healthcare, a
leading partner for healthcare companies seeking to grow their business
in Asia, will provide distribution and logistics services for Panion & BF
Biotech’s full range of products to hospitals, clinics, pharmacies and other
medical channels.
DKSH Taiwan leverages on its state-of-the-art healthcare distribution
center that is certified as per the most stringent pharmaceutical
manufacturing standards, including PIC/S GMP, GDP and ISO13485.
DKSH will also provide repackaging services to Panion & BF Biotech to
make the company’s products suitable for the over-the-counter market.
Fei-Ju Lin, Administration and Management Manager, Panion & BF
Biotech, stated: “DKSH is a trustworthy partner that emphasizes integrity.
Through DKSH Taiwan’s experience in the healthcare industry and
network of unique scope and depth, more consumers will be able to
experience products provided by Panion & BF Biotech.”
Ronald Linke, Vice President, Business Unit Healthcare, DKSH Taiwan,
said: “Panion & BF Biotech is a prime example of a successful
Taiwanese healthcare company. The company’s high-quality products
deserve to reach a larger audience. Our industry experts will use their indepth knowledge and network to expand the company’s products in the
market.”
The agreement will further strengthen DKSH’s market position in the
region while contributing incrementally to the Group’s overall profitability
over time.
About Panion & BF Biotech
Panion & BF Biotech Inc. was established in 1976. Over time, the
company has evolved into a highly diversified biotech and
pharmaceutical company focusing on three core business sectors:
Pharmaceuticals (new drug development & generic drug manufacture),
Cosmeceuticals, and Nutraceuticals, and is vertically integrated from
R&D, manufacturing, and marketing & sales. In addition, the Company
has obtained both PIC/S GMP and Cosmetic GMP recognition for quality
manufacturing standards, thereby giving PBF the ability to provide
customers with most promised service and products.
Page 1
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on
Asia. As the term "Market Expansion Services" suggests, DKSH helps
other companies and brands to grow their business in new or existing
markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a
global company headquartered in Zurich. With 735 business locations in
35 countries – 710 of them in Asia – and 27,200 specialized staff, DKSH
generated net sales of CHF 9.6 billion in 2013.
DKSH Business Unit Healthcare is the leading Market Expansion
Services provider for healthcare companies seeking to grow their
business in Asia. Custom-made offerings comprise registration and
market entry studies as well as importation, customs clearance,
marketing and sales to physical distribution, invoicing and cash
collection. Products available through DKSH Healthcare include ethical
pharmaceuticals, consumer health, over-the-counter (OTC), as well as
medical devices. With 150 business locations in 14 countries and around
9,050 specialized staff, Business Unit Healthcare serves over 160,000
customers and generated net sales of around CHF 4.3 billion in 2013.
For further information, please contact:
DKSH Taiwan
Irene Chen
Branding & Communications Manager
Phone +886 2 8752 7611
Mobile +886 963 816 010
[email protected]
DKSH Healthcare
Kalle Siebring
Communications Manager
Business Units Consumer Goods and Healthcare
Phone +66 2 220 9739
[email protected]
Page 2

Download Report